Researchers Trial Covid-19 Vaccine Through the Nose

SOLOPOS.COM – Scientists are researching the administration of a vaccine through the nose. (Illustration/Freepik)

Solopos.com, SOLO-Scientists are working on an alternative to a Covid-19 vaccine that can be given without an injection, but through the nose. The results of this study have provided a positive signal so far.

As quoted from DW, Saturday (22/1/2022), scientists in Mexico are currently trying to create a vaccine that can be administered through the nose called Patria – which means homeland in Spanish. They hope this vaccine can start clinical trials soon.

Head of the Department of Microbiology at the Ichan School of Medicine, Mount Sinai Hospital, United States (US) Peter Palese, developed the main ingredients used in nasal vaccines or vaccines through the nose with his research team.

Also Read: Different, These are the Side Effects of Pfizer, Moderna, AstraZeneca Booster Vaccines

In an interview, he said one of the main advantages of the nasal vaccine is its ability to be refrigerated at 2-4 degrees Celsius, rather than the extremely low temperatures for Pfizer and Moderna. “It’s much, much cheaper to manufacture this vaccine than the mRNA vaccine by Pfizer and Moderna,” Palese said.

Phases one and two trials are currently being facilitated in parallel due to the urgency of the pandemic. People from five countries are involved in the trial and preliminary data are expected this July.

“It works well in animals, we have fantastic and interesting research on hamsters and mice, but obviously rats and hamsters are not humans,” Palese said. Between on Saturday (22/1/2022).

Also Read: UNS Solo Clinical Pathologist: Covid-19 Vaccine Booster is Important, But..

On the other hand, scientists at Washington University in St. Louis are also working on a COVID-19 nasal vaccine. The research team, led by viral immunologist Michael Diamond and oncologist David Curial, found that mice that received a single nasal dose of the vaccine were fully protected from SARS-CoV-2.

But mice that received the same vaccine by injection were only partially protected. To make the vaccine, the researchers inserted the SARS-CoV-2 spike protein in the adenovirus, which causes the common cold. But they change the adenovirus so it can’t cause disease. This allows the body to develop an immune defense against spike protein.

Also Read: Symptoms of Omicron vary depending on the dose of the Covid-19 vaccine

“A single dose produces a strong immune response. Vaccines that require two doses for full protection are less effective because some people, for various reasons, never receive a second dose,” said Curial. Then, because the vaccine does not contain live virus, it would be a good choice for people with compromised immune systems such as cancer, HIV and diabetes patients, scientists argue.

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.